Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May:63 Suppl 3:S26-S34.
doi: 10.1111/trf.17373. Epub 2023 Apr 21.

Epsilon aminocaproic acid is associated with acute kidney injury after life-threatening hemorrhage in children

Julia H Kolodziej  1 , Christine M Leeper  2 , Julie C Leonard  3 , Cassandra D Josephson  4 , Mazen S Zenati  5 , Philip C Spinella  2   6
Affiliations

Epsilon aminocaproic acid is associated with acute kidney injury after life-threatening hemorrhage in children

Julia H Kolodziej et al. Transfusion. 2023 May.

Abstract

Background: Antifibrinolytic medications have been associated with reduced mortality in pediatric hemorrhage but may contribute to adverse events such as acute kidney injury (AKI).

Study design and methods: We conducted a secondary analysis of the MAssive Transfusion in Children (MATIC), a prospectively collected database of children with life-threatening hemorrhage (LTH), and evaluated for risk of adverse events with either antifibrinolytic treatment, epsilon aminocaproic acid (EACA) or tranexamic acid (TXA). The primary outcome was AKI and secondary outcomes were acute respiratory distress syndrome (ARDS) and sepsis.

Results: Of 448 children included, median (interquartile range) age was 7 (2-15) years, 55% were male, and LTH etiology was 46% trauma, 34% operative, and 20% medical. Three hundred and ninety-three patients did not receive an antifibrinolytic (88%); 37 (8%) received TXA and 18 (4%) received EACA. Sixty-seven (17.1%) patients in the no antifibrinolytic group developed AKI, 6 (16.2%) patients in the TXA group, and 9 (50%) patients in the EACA group (p = .002). After adjusting for cardiothoracic surgery, cyanotic heart disease, preexisting renal disease, lowest hemoglobin pre-LTH, and total weight-adjusted transfusion volume during the LTH, the EACA group had increased risk of AKI (adjusted odds ratio 3.3 [95% CI: 1.0-10.3]) compared to no antifibrinolytic. TXA was not associated with AKI. Neither antifibrinolytic treatment was associated with ARDS or sepsis.

Conclusion: Administration of EACA during LTH may increase the risk of AKI. Additional studies are needed to compare the risk of AKI between EACA and TXA in pediatric patients.

Keywords: Hemostasis.

PubMed Disclaimer

References

REFERENCES

    1. Cunningham RM, Walton MA, Carter PM. The major causes of death in children and adolescents in the United States. N Engl J Med. 2018;379(25):2468-75. https://doi.org/10.1056/NEJMsr1804754
    1. Shroyer MC, Griffin RL, Mortellaro VE, Russell RT. Massive transfusion in pediatric trauma: analysis of the National Trauma Databank. J Surg Res. 2017;208:166-72. https://doi.org/10.1016/j.jss.2016.09.039
    1. Leonard JC, Josephson CD, Luther JF, Wisniewski SR, Allen C, Chiusolo F, et al. Life-threatening bleeding in children: a prospective observational study. Crit Care Med. 2021;49(11):1943-54. https://doi.org/10.1097/CCM.0000000000005075
    1. Butler EK, Mills BM, Arbabi S, Bulger EM, Vavilala MS, Groner JI, et al. Association of blood component ratios with 24-hour mortality in injured children receiving massive transfusion. Crit Care Med. 2019;47(7):975-83. https://doi.org/10.1097/CCM.0000000000003708
    1. Camazine MN, Hemmila MR, Leonard JC, Jacobs RA, Horst JA, Kozar RA, et al. Massive transfusion policies at trauma centers participating in the American College of Surgeons trauma quality improvement program. J Trauma Acute Care Surg. 2015;78(6):S48-53. https://doi.org/10.1097/TA.0000000000000641

Publication types

LinkOut - more resources